Finance

Beta
Lists
9969:HKG
InnoCare Pharma Ltd
HK$11.63
+3.65%
(+0.41) 1D
May 29, 4:08:25 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 9969...
Open
HK$11.52
High
HK$11.88
Low
HK$11.21
Mkt. cap
25.23B
Avg. vol.
7.90M
Volume
14.98M
P/E ratio
26.84
52-wk high
HK$20.62
52-wk low
HK$10.30
EPS
HK$0.43
No. of employees
1K
Open
HK$11.52
High
HK$11.88
Low
HK$11.21
Mkt. cap
25.23B
Avg. vol.
7.90M
Volume
14.98M
P/E ratio
26.84
52-wk high
HK$20.62
52-wk low
HK$10.30
EPS
HK$0.43
No. of employees
1K
News stories
From sources across the web
About InnoCare Pharma Ltd
CEOJasmine Cui
Employees1.26K
FoundedNov 3, 2015
Headquarters-
SectorBiotechnology
Websiteinnocarepharma.com
Last report
Apr 23, 2026
Fiscal period
Q1 2026
EPS / Est. (CNY)
- / -
Revenue / Est. (CNY)
528.63M / 654.10M
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
350.17M
383.89M
1.26B
528.63M
Cost of goods sold
40.65M
48.46M
66.11M
62.72M
Cost of revenue
40.65M
48.46M
66.11M
62.72M
Research and development expenses
242.10M
226.35M
275.57M
229.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
170.90M
187.93M
243.50M
162.45M
Operating expense
417.82M
388.22M
560.08M
392.10M
Total operating expenses
458.46M
436.68M
626.19M
454.82M
Operating income
-108.29M
-52.79M
633.39M
73.81M
Other non operating income
-3.54M
26.02M
-26.67M
11.13M
EBT including unusual items
-46.98M
-33.60M
719.92M
104.85M
EBT excluding unusual items
-75.47M
-8.17M
673.62M
101.24M
Income tax expense
3.14M
2.72M
3.79M
2.40M
Effective tax rate
-6.68%
-8.09%
0.53%
2.29%
Other operating expenses
4.72M
-25.90M
40.29M
-320.57K
Net income
-48.06M
-34.32M
706.88M
105.82M
Net profit margin
-13.72%
-8.94%
56.12%
20.02%
Earnings per share
-
-
-
-
Interest and investment income
38.57M
44.67M
47.46M
30.69M
Interest expense
-13.70M
-14.49M
-12.42M
-14.38M
Net interest expenses
24.87M
30.17M
35.04M
16.30M
Depreciation and amortization charges
-
-
-
-
EBITDA
-88.69M
-36.03M
652.95M
93.37M
Gain or loss from assets sale
-3.40K
3.40K
-3.40K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer